Egybiotech was established in August 2012, by primary founder Dr. Noha Awad, as a private research organization working primarily in the area of health, with focus on biotechnology research applications. Besides conducting commissioned research projects and conducting research training workshops, our main interest is to develop our own biotech products through our own R&D process. We have a broad research portfolio in multiple areas of cancer research, health service evaluation, and research at the interface of health and social science. The main focus is to produce, validate and patent molecular diagnostics based on multi-gene assays capable of predicting incidence or outcome of disease or treatment.
Dr. Amr Abdelaziz provided the angel funding for Egybiotech at a very early stage, and brought to it the added value of his scientific, academic and entrepreneurial expertise . He developed the research portfolio of the company with Noha and was pivotal in terms of business development. The company is now ready for round B of VC funding.
Throughout its establishment and growth, Mr. Ahmed Desouky provided the financial management expertise, both in areas of company finance and as research project finance management.